These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 29476612)
1. Prognostic performance of serial in-hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study. Düngen HD; Tscholl V; Obradovic D; Radenovic S; Matic D; Musial Bright L; Tahirovic E; Marx A; Inkrot S; Hashemi D; Veskovic J; Apostolovic S; von Haehling S; Doehner W; Cvetinovic N; Lainscak M; Pieske B; Edelmann F; Trippel T; Loncar G ESC Heart Fail; 2018 Apr; 5(2):288-296. PubMed ID: 29476612 [TBL] [Abstract][Full Text] [Related]
2. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department. Bahrmann P; Bahrmann A; Hofner B; Christ M; Achenbach S; Sieber CC; Bertsch T Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708 [TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure. Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002 [TBL] [Abstract][Full Text] [Related]
4. Short-Term Influence of Radiofrequency Ablation on NT-proBNP, MR-proANP, Copeptin, and MR-proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF Study. Charitakis E; Walfridsson H; Alehagen U J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633393 [TBL] [Abstract][Full Text] [Related]
18. Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure. Miller WL; Hartman KA; Grill DE; Struck J; Bergmann A; Jaffe AS Heart; 2012 Mar; 98(5):389-94. PubMed ID: 22194151 [TBL] [Abstract][Full Text] [Related]
19. Mid-regional pro-adrenomedullin in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study. Pervez MO; Lyngbakken MN; Myhre PL; Brynildsen J; Langsjøen EC; Høiseth AD; Christensen G; Omland T; Røsjø H Clin Biochem; 2017 May; 50(7-8):394-400. PubMed ID: 28065681 [TBL] [Abstract][Full Text] [Related]
20. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure. Alehagen U; Dahlström U; Rehfeld JF; Goetze JP J Card Fail; 2013 Jan; 19(1):31-9. PubMed ID: 23273592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]